概括
胆固醇胺正在被高度暴露的人使用,但科学证据不足以证实其长期健康益处. 需要更多的研究来验证这种治疗方法.
科学领域:
- 环境健康 环境健康
- 药理学 药理学是指药理学的学科.
背景情况:
- 某些人群面临环境毒素的高暴露.
- 胆胺是一种胆酸分离剂,正在作为一种潜在的治疗剂进行探索.
研究的目的:
- 评估当前对高暴露个体的胆固醇胺的使用情况.
- 评估有关胆固醇胺治疗对健康的长期影响的现有证据.
主要方法:
- 审查现有的文献和临床观察.
- 对有关胆固醇胺使用的事报告的分析.
主要成果:
- 一些高度暴露的个体已经开始使用胆固醇胺.
- 目前缺乏支持长期健康改善的强有力的科学证据.
结论:
- 虽然胆固醇胺正在使用,但其在高度暴露的人群中对长期健康的有效性仍然未被证明.
- 需要进一步进行严格的临床试验,以确定胆固醇胺在此症候群中的安全性和有效性.
相关概念视频
Cholesterol: Significance and Regulation
1.4K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.4K
Pharmacokinetics: Drug–Drug Interactions
442
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
442
Bioequivalence of Drugs: Drugs with Multiple Indications
159
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
159
FDA Approved Drugs: Changes to Approved Drugs
268
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
268
Factors Influencing Drug Absorption: Drug Dissolution
1.2K
The pharmacokinetic journey of drugs from solid oral dosage forms into systemic circulation is multifaceted. It begins with disintegration, a prerequisite ensuring a solid dosage form's subdivision into minute particles. Dissolution occurs next as these granulated entities solubilize in gastrointestinal fluids. This solubilization is crucial for the succeeding stage, permeation, which describes the traversal of the drug across the intestinal membrane and its subsequent entry into the blood...
1.2K
Factors Affecting Protein-Drug Binding: Drug-Related Factors
485
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
485


